---
$id: https://graph.org.ai/products/commodity/51431806
$type: Product
source: UNSPSC
code: "51431806"
title: "Methyldopa anhydrous"
class: "51431800"
classTitle: "Antihypertensive benzene derivatives and benzimidazoles and benzofurans and catecholamines"
family: "51430000"
familyTitle: "Antihypertensive drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Methyldopa anhydrous

**UNSPSC Code**: 51431806
**Class**: [Antihypertensive benzene derivatives and benzimidazoles and benzofurans and catecholamines](Antihypertensive benzene derivatives and benzimidazoles and benzofurans and catecholamines.mdx)
**Family**: [Antihypertensive drugs](../Antihypertensive drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine agonist and antihypertensive agent with the molecular formula C10H13NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M4R0H12F6M, chemically known as l-3-(3,4-dihydroxyphenyl)-2-methylalanine, but more generally known as methyldopa anhydrous, which bears US NIH Compound Identifier 4138. European Medicines Agency schedules methyldopa anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08867MIG. Most nations, for tariff purposes, schedule methyldopa anhydrous under HS 29225000. SMILES: C[C@](CC1CCC(C(C1)O)O)(C(=O)O)N.

